Norman Ruthven Saunders

Norman Ruthven Saunders

Auto-generated profile, based on publicly available information

Norman Ruthven Saunders

Monash University

Research Focus & Metrics

Academic Career Length

60Years (1967-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2011 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
ENEdward A. Neuwelt
Edward A. Neuwelt
BBBjörn Bauer
Björn Bauer
CFChristoph Fahlke
Christoph Fahlke
Gert FrickerGert Fricker
Gert Fricker
CIConstantino Iadecola
Constantino Iadecola
LDLester R. Drewes
Lester R. Drewes

1 January 2012 in Frontiers in Pharmacology
Verified
Journal Article
Open access
NSNorman R. Saunders
Norman R. Saunders
SLShane Liddelow
Shane Liddelow
KDKatarzyna M. Dziegielewska
Katarzyna M. Dziegielewska
The adult brain functions within a well-controlled stable environment, the properties of which are determined by cellular exchange mechanisms superimposed on the diffusion restraint provided by tight junctions at interfaces between blood, brain and cerebrospinal fluid (CSF). These interfaces are referred to as “the” blood–brain barrier. It is widely believed that in embryos and newborns, this barrier is immature or “leaky,” rendering the developing brain more vulnerable to drugs or toxins entering the fetal circulation from the mother. New evidence shows that many adult mechanisms, including functionally effective tight junctions are present in embryonic brain and some transporters are more active during development than in the adult. Additionally, some mechanisms present in embryos are not present in adults, e.g., specific transport of plasma proteins across the blood–CSF barrier and embryo-specific intercellular junctions between neuroependymal cells lining the ventricles. However developing cerebral vessels appear to be more fragile than in the adult. Together these properties may render developing brains more vulnerable to drugs, toxins, and pathological conditions, contributing to cerebral damage and later neurological disorders. In addition, after birth loss of protection by efflux transporters in placenta may also render the neonatal brain more vulnerable than in the fetus.

29 October 2015 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
NSNorman R. Saunders
Norman R. Saunders
KDKatarzyna M. Dziegielewska
Katarzyna M. Dziegielewska
KMKjeld Møllgård
Kjeld Møllgård
MHMark D. Habgood
Mark D. Habgood
In recent years there has been a resurgence of interest in brain barriers and various roles their intrinsic mechanisms may play in neurological disorders. Such studies require suitable models and markers to demonstrate integrity and functional changes at the interfaces between blood, brain and cerebrospinal fluid. Studies of brain barrier mechanisms and measurements of plasma volume using dyes have a long-standing history, dating back to the late 19th-Century. Their use continues in spite of their known serious limitations in in vivo applications. These were well known when first introduced, but seem to have been forgotten since. Understanding these limitations is important because Evans blue is still the most commonly used marker of brain barrier integrity and those using it seem oblivious to problems arising from its in vivo application. The introduction of HRP in the mid 20th-Century was an important advance because its reaction product can be visualized at the electron microscopical level. Advantages and disadvantages these markers will be discussed together with a critical evaluation of alternative approaches. There is no single marker suitable for all purposes. A combination of different sized, visualisable dextrans and radiolabelled molecules currently seems to be the most appropriate approach for qualitative and quantitative assessment of barrier integrity.

16 December 2014 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
NSNorman R. Saunders
Norman R. Saunders
JDJean-Jacques Dreifuss
Jean-Jacques Dreifuss
KDKatarzyna M. Dziegielewska
Katarzyna M. Dziegielewska
PJPia Johansson
Pia Johansson
MHMark D. Habgood
Mark D. Habgood
HBHans-Christian Bauer
Hans-Christian Bauer
Careful examination of relevant literature shows that many of the most cherished concepts of the blood-brain barrier are incorrect. These include an almost mythological belief in its immaturity that is unfortunately often equated with absence or at least leakiness in the embryo and fetus. The original concept of a blood-brain barrier is often attributed to Ehrlich; however, he did not accept that permeability of cerebral vessels was different from other organs. Goldmann is often credited with the first experiments showing dye (trypan blue) exclusion from the brain when injected systemically, but not when injected directly into it. Rarely cited are earlier experiments of Bouffard and of Franke who showed methylene blue and trypan red stained all tissues except the brain. The term “blood-brain barrier” “Blut-Hirnschranke” is often attributed to Lewandowsky, but it does not appear in his papers. The first person to use this term seems to be Stern in the early 1920s. Studies in embryos by Stern & colleagues, Weed and Wislocki showed results similar to those in adult animals. These were well-conducted experiments made a century ago, thus the persistence of a belief in barrier immaturity is puzzling. As discussed in this review, evidence for this belief, is of poor experimental quality, often misinterpreted and often not properly cited. The functional state of blood-brain barrier mechanisms in the fetus is an important biological phenomenon with implications for normal brain development. It is also important for clinicians to have proper evidence on which to advise pregnant women who may need to take medications for serious medical conditions. Beliefs in immaturity of the blood-brain barrier have held the field back for decades. Their history illustrates the importance of taking account of all the evidence and assessing its quality, rather than selecting papers that supports a preconceived notion or intuitive belief. This review attempts to right the wrongs. Based on car

12 January 2007 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
MHM. D. Habgood
M. D. Habgood
NBN. Bye
N. Bye
KDK. M. Dziegielewska
K. M. Dziegielewska
CEC. J. Ek
C. J. Ek
MLMichael Aron Lane
Michael Aron Lane
NSN. R. Saunders
N. R. Saunders

1 June 2012 in NeuroToxicology
Verified
Journal Article
Closed access
CEC. Joakim Ek
C. Joakim Ek
KDKatarzyna M. Dziegielewska
Katarzyna M. Dziegielewska
MHMark D. Habgood
Mark D. Habgood
NSNorman R. Saunders
Norman R. Saunders